• My Profile
  • Saved articles
  • Newsletters
  • Sign out
UserSign in
  • Register
  • Sign in
News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
World Cup 2026
Football
Cricket
F1
Tennis
Combat Sports
Cycling
Puzzles
Newsletters
TN Magazine
  • International Edition
  • UAE Edition
Podcasts Newsletters Follow us App Video
PuzzlesNewslettersTN MagazineWeekend
News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
World Cup 2026
Football
Cricket
F1
Tennis
Combat Sports
Cycling
News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
World Cup 2026
Football
Cricket
F1
Tennis
Combat Sports
Cycling
News
Business
Opinion
Future
Climate
Health
Culture
Lifestyle
Sport
Puzzles
Newsletters
TN Magazine
  • My Profile
  • Saved articles
  • Newsletters
  • Sign out
UserSign in
  • Register
  • Sign in

Moderna

The latest news on Moderna, including vaccine, stock and share price updates

Pharmaceutical companies are revisiting strategies as demand for Covid-19 vaccines falls. Reuters

Rethink for big pharma as demand for Covid-19 vaccines falls

EconomyAugust 11, 2023
A British government deal with Moderna will lead to a centre developing 250 million vaccines a year. EPA

New UK Moderna vaccine centre to produce 250 million doses a year

UKDecember 22, 2022
The Afrigen Biologics & Vaccines lab is part of the WHO's mRNA technology transfer hub in South Africa. Bloomberg

Moderna will help WHO develop Covid-19 vaccine, but Pfizer declines

TechnologySeptember 19, 2022
Moderna alleges that Pfizer-BioNTech, without permission, copied technology that Moderna had patented between 2010 and 2016. EPA
Play9:35:17

Moderna sues Pfizer-BioNTech for patent infringement over Covid-19 vaccine

CoronavirusAugust 26, 2022
A man receives a dose of the Moderna Covid-19 vaccine at Babington Hospital, Derbyshire, in December 2021. AFP
Play11:49:20

World's first approval of 'next generation' Omicron vaccine booster

CoronavirusAugust 15, 2022
A 2-year-old prepares to receive a Moderna Covid-19 vaccination in Salt Lake City, Utah. AP

Vaccinations for children under 5 begin in US

USJune 21, 2022
Moderna's revenue surged to more than $6 billion in the first quarter. Reuters

Moderna's Q1 profit soars as Covid-19 vaccine sales boost revenue

MarketsMay 04, 2022
A mother with her child, 3, at an appointment for a Moderna Covid-19 vaccine trial. AP

Moderna seeks Covid vaccine authorisation for US children under 5

USApril 28, 2022
Moderna is in the late stages of talks with the British government about opening a research and manufacturing centre in the UK, according to reports. Getty Images

Moderna ‘plans major investment deal in UK research and manufacturing’

UKFebruary 15, 2022
A Moderna building in Cambridge, Massachusetts, the US. AP

Moderna starts study of Omicron-specific vaccine booster shot

USJanuary 26, 2022
Results from a study in Israel showed both Pfizer-BioNTech and Moderna vaccines were safe and produced substantial antibodies, but were only partially effective in defending against Omicron. Reuters

Fourth booster shot less effective against Omicron, Israel research finds

CoronavirusJanuary 19, 2022
CEO of Moderna Stephane Bancel speaks during a remote panel at the Davos Agenda 2022 in Cologny, Switzerland. EPA
Camera8

Dual vaccine to fight Covid and flu 'likely' next year, WEF hears

UAEJanuary 18, 2022
Moderna says it has shipped 807 million vaccine doses in 2021. Reuters

Moderna vaccine order for 2022 hits £13.6 billion

CoronavirusJanuary 10, 2022
Vaccine maker Moderna says the Omicron coronavirus variant could affect the potency of its current shot. Reuters

Moderna says Omicron booster could be ready by March

WorldDecember 02, 2021

Don't freak out over Omicron, says BioNTech chief

UKDecember 01, 2021
People queue to receive a dose each of a COVID-19 vaccine on the second day of a national lockdown to combat soaring coronavirus infections, in Vienna, Austria, Tuesday, Nov. 23, 2021. (AP Photo / Vadim Ghirda)
Camera15

No, AstraZeneca can’t claim that T-cells trump antibodies in the fight against Covid-19

CommentNovember 23, 2021
Read more
The National News Logo
IPSO regulated

News
UAE
Gulf
MENA
US
UK
Europe
Asia
Business
Aviation
Economy
Energy
Money
Property
Banking
Markets
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Future
Science
Space
Technology
Climate
Environment
Road to Net Zero
Health
Culture
Art & Design
Books
Film & TV
Music & On-stage
Pop Culture
Lifestyle
Travel
Fashion & Beauty
Food
Motoring
Luxury
Home & Garden
Wellbeing
Things to do
Sport
Football
Cricket
Olympics
F1
Tennis
Combat Sports
Cycling
Weekend
Living in the UAE
TN Magazine
Podcasts Newsletters Read E-Paper Print Subscriptions Video App
About UsContact UsWork With UsAdvertise With UsTerms & ConditionsPrivacy PolicyCookie PolicySitemapArchiveRegistration FAQsRosalynn Carter Fellowship
IPSO regulated
Follow us
Get news alerts from
The National logo
You can manage notifications at any time by clicking the notifications icon.